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Abstract: This work follows an ethnobotanical study that took place in the island of Mayotte (France),
which pointed out the potential properties of Litchi chinensis Sonn. roots when used to enhance skin
health and appearance. Through in vitro testing of a crude methanolic extract, high anti-tyrosinase
(skin whitening effect) and antioxidant activities (skin soothing effect) could be measured. HPLC
successive bio-guided fractionation steps allowed the purification of one of the compounds responsible
for the biological activities. The isolated compound was characterized by UV, IR, MS and 2D-NMR,
revealing, for the first time in Litchi chinensis Sonn. roots, an A-type proanthocyanidin and thus
revealing a consensus among the traditional use shown by the ethnobotanical study, in vitro biological
activities and chemical characterization.




An ethnobotanical study which took place in the island of Mayotte [1] led to the conclusion that
many plants are used traditionally among inhabitants of the island to promote health and for use
in dermatological applications. Using indicators such as the Informant Agreement Ratio developed
by Trotter & Logan, 1986 [2], species of interest were selected for further studies. In vitro biological
activities measurements realized on several crude extracts of the selected plants revealed that Litchi
chinensis Sonn. roots, traditionally used for skin whitening and soothing, have high anti-tyrosinase
and antioxidant activities.
1.2. Litchi
The species Litchi chinensis Sonn. which belongs to the Sapindaceae family [3,4] mainly originates
from southeast Asia but is now a cultivated economic crop in the countries around the world with
appropriate climate for its culture [5,6]. The Litchi Sonn. genus only contains one identified species
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composed of three subspecies: L. chinensis subsp. chinensis Forest & Kim Starr, L. chinensis subsp.
phippinensis Radlk, and L. chinensis subsp. javensis Leenh. [7,8]. The first one is mainly found in
China [4], the second subspecies is native from the Philippines, New Guinea, Malay Peninsula, and
Indonesia and the last one is endemic from Java. Due to their commercial interest, L. chinensis subsp.
chinensis Forest & Kim Starr and L. chinensis subsp. phippinensis Radlk are found all around the Indian
ocean [3]. In Mayotte, only the subspecies chinensis is encountered [9].
L. chinensis is an evergreen, medium sized round-topped tree. Its leaves are leathery, pinnate or
lanceolate, acuminate and glabrous. Its inflorescence is a branched panicle. The flowers are small
going from white to pale yellow, with a tetramerous calyx without a corolla. They are functionally
male and female. The litchi fruits are heart shaped to round covered by a rough rind of pericarp going
from light pink to red. The root system is strongly influenced by the soil as well as the propagation
technique used. Even if some specimens present a tap root, most of the Litchi trees found nowadays
have fibrous roots (Figure 1) found at depth between 0 and 60 cm [4,10,11].
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Skin pigmentation is due to melanogenesis, a biochemical phenomenon that takes place in the basal
layer of the epidermis. The melanins are produced there and provide the skin with natural protection
against harmful effects of UV rays. Melanogenesis can be disturbed due to external aggressions like
UV, hormonal disturbances or aging and may result in the appearance of hyperpigmentation spots.
The cosmetics sector is actively looking for compounds capable of inhibiting tyrosinase activity with
a view to develop ethnic or anti-spot/anti-aging cosmetics [14].
Ethnobotanical study and preliminary anti-tyrosinase and antioxidant in vitro activity
measurements incited us to further study Litchi chinensis root extracts by purifying and characterizing
a compound involved within the observed biological activities.
2. Materials and Methods
DMAC (4-dimethylamincinnamaldehyde), L-DOPA (3,4-dihydroxy-L-phenylalanine), kojic acid,
formic acid (FA), K3PO4, TROLOX (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), DPPH
(2,2-diphenyl-1-picrylhydrazyl), tyrosinase (E.C. 1.14.18.1) from mushroom, ammonium formate
were purchased from Sigma Aldrich (Darmstadt, Germany). NaH2PO4 was purchased from Merck
(Darmstadt, Germany) and Na2HPO4 from UCB (Bruxelles, Belgium). All HPLC grade and technical
solvents as well as absolute ethanol used in this work were purchased from VWR (Leuven, Belgium).
2.1. Plant Material
During the ethnobotanical study, Litchi chinensis roots were collected around the village of Coconi,
(Mayotte Island, 12◦50′03.3” S 45◦08′24.2” E) and a specimen was stored into the CBNM’s herbaria for
proofing reasons (referenced as MAO00051). A total of three independent collects occurred between
2014 and 2017 on trees of similar size in the same area. The L. chinensis’s roots were dried for 48 h at 40
± 1 ◦C using a drying oven, they were then powdered, vacuum packed and stored at −22 ± 1 ◦C until
being used. Extractions and purifications were therefore carried out on three completely independent
biological samples.
2.2. Sample Preparation
Twenty grams of L. chinensis roots were precisely weighted and extracted with 400 mL of solvent
in a Soxhlet apparatus. Extractions were made using either HPLC grade methanol or HPLC grade
dichloromethane, and this led to the collection of a polar and a less-polar extract. The extracts were then
evaporated at 40 ± 1 ◦C using a rotating evaporator (Sigma Aldrich, Darmstadt, Germany). The dried
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extracts were kept at −22 ± 1 ◦C until use. The polar samples were solubilized in a small amount of
pure ethyl alcohol and the non-polar extracts were solubilized in HPLC grade dimethyl sulfoxide.
The solvents were added gradually under ultrasonic bath until complete solubilization.
2.3. DPPH Antioxidant Activity
In order to determine the antioxidant potency of the plant samples, a protocol based on the DPPH
method and adapted from M. S. Blois 1965 [15] was used. A 2.10−4 M DPPH solution was prepared using
methanol and was then added to different dilution of the plant extracts. The solution was left to react
for 30 min and then observed at 517 nm by UV/VIS spectrophotometer (Ultrospec 7000 from Biochrom,
Cambridge, UK). The polar plant extract was diluted using HPLC grade methanol and the non-polar
extract was diluted using HPLC grade ethyl acetate. The 10−2 and 10−3 dilutions were applied to
the plant extracts. A 1:1 (v/v) ratio was applied with the reagent and the plant samples. The positive
control both kind of samples was TROLOX (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
2.10−3 M in methanol and blank was 100% methanol.
2.4. Tyrosinase Inhibition
Tyrosinase (EC 1.14.18.1) is a key enzyme in the melanogenesis pathway. In this work,
the polyphenol oxidase activity was exploited based on the adaptation of the work of Rangkadilok et al.,
2007 [16]. Through the consumption of L-DOPA, it produces dopachromes that are detected/measured
at 475 nm. In order to evaluate the impact of the plant extract on the synthesis of these dopachromes,
inhibitions were compared with the inhibitory action of 1 mM kojic acid in phosphate buffer
(0.05 M–pH 6.5). Dilution factors of 10−1, 10−2 and 10−3 were applied to the samples using the same
phosphate buffer. The substrate solution was made of a 1 mM solution of L-DOPA in distilled H2O
and the enzymatic suspension was made at a 625 U/mL concentration in phosphate buffer. As oxygen
is also part of the enzymatic reaction as a co-substrate, the phosphate buffer used in the reactive mix
was saturated with pure oxygen for 30 min at room temperature prior to the analysis.
The enzymatic reaction was performed by mixing 100 µL of sample with 50 µL of tyrosinase and
250 µL of oxygenated phosphate buffer. This mixture was left to incubate for 15 min, and then added
in a quartz absorption cell along with 400 µL of the substrate solution. The synthesis of dopachromes
was observed in real time, and the absorbance was measured every 15 s for 5 min at 475 nm.
2.5. Bio-Guided Fractionation
Throughout the purification process, the anti-tyrosinase inhibition test and the antioxidant
test were conducted for all fractions. Based on preliminary observation, the chromatograms were
systematically recorded at 280 nm as it gave the best contrast; however, in order to control potential left
out compounds, other wavelengths were also registered (254 nm, 310 nm and 360 nm) with the cut-off
for eluants being at 190 nm.
2.5.1. Preparative HPLC
A first preparative HPLC step was conducted as follows: the column was a 150 × 21.2 mm–5 µm
RP C8 column (Strategy, Interchrom, Interchim, Montluçon, France). Two mL solution (100 mg/mL)
of the samples was injected at a 20 mL/min flow. The mobile phase was composed of solvent A:
acetonitrile (CAN)–0.1% formic acid and solvent B: H2O–0.1% formic acid, and the optimized gradient
was from 100% B to 20% (A)–80% (B) in 50 min, and then a final hold for 5 min. The mobile phase
reached 60% (A)–40% (B) at 65:00 min and was then reset to 100% (B) in 10 min. From this first cycle,
17 fractions were collected and tested for the two biological activities. The most potent fraction went
through a second preparative HPLC purification process.
The second preparative HPLC was conducted on this fraction with the same apparatus; the detector
was set at 280 nm; 2 mL of sample at a 100 mg/mL were injected at a 16 mL/min flow rate. The instrument
was fitted with a 250 × 22 mm–10 µm RP C4 column (Protein from Vydac, Hicrom, Lutterworth, UK).
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The same solvents were used for this fractionation. The gradient started with a steady step with 0%
(A)–100% (B) between the 00:00 min mark and the 05:00 min mark. At the 10:00 min mark, it had
reached 5% (A)–95% (B). At the 55:00 min mark, it had gone down to 30% (A)–70% (B); from that
point it went back up to 0% (A)–100% (B) at the 57:00 min mark. From this second cycle, 5 fractions
were collected and tested for the two biological activities. The most potent fraction was once again
fractionated using an analytical HPLC setup mounted with a fraction collector.
2.5.2. Purification through Analytical HPLC
A Hewlett-Packard Agilent 1200 HPLC (Santa Clara, CA, USA) with a Multi Wave detector
set at 280 nm was used, and the following parameters where applied. Ten microliter of 10 mg/mL
sample was injected at a 0.5 mL/min flow rate. The solvent used were the same as the one used
for the preparative HPLC. The instrument was equipped with a 250 × 4.6 mm–5 µm RP C8 column
(Strategy from Uptisphere, Interchim, Montluçon, France). The gradient starts at 0% (A)–100% (B) for
10 min; then from the 10:00 min mark to the 55:00 min mark, it goes down to 20% (A)–80% (B); this is
followed by a drop reaching 60% (A)–40% (B) at the 57:00 min mark. It finishes at the 59:00 min mark
with a 0% (A)–100% (B) mobile phase. From this fractionation 5 fractions were collected and tested for
the two biological activities. Once the purification process was complete, the compound was kept at 7
± 1 ◦C in a dark container for a maximum 48 h before undergoing the analytical steps.
2.6. Molecular Characterization
The molecular characterization of the target compound was realized by combining IR, UV,
2D-NMR and MS techniques.
2.6.1. IR
The dry sample was analyzed using a Shimazu IR Affinity-1S FTIR (Nakagyo, Japan)
spectrophotometer in transmission mode. The purified powder was placed directly on the diamond in
order to establish its IR spectrum. The FT-IR spectrum of the sample was scanned between 4000 and
400 cm−1.
2.6.2. UV
The UV spectra was obtained with a Ultrospec 7000 (Biochrom, Holliston, MA, USA)
spectrophotometer. The sample was diluted at a 0.3 mg/mL in the MeOH and the absorbance
was recorded in the UV/VIS range between 200 to 600 nm.
2.6.3. MS
The purified fraction of interest was solubilized in HPLC grade MeOH at a 1 mg/mL concentration.
It was analyzed using an Agilent 1100 HPLC (Santa Clara, CA, USA) mounted with an Inertsil ODS-3
3 µm 3 × 100 mm column and using the following gradient: acetonitrile: mQ water (85:15, solvent
B) and mQ water (solvent A) + 0.2% formic acid and 12 mM ammonium formate. One minute of
53% B was followed by a linear increase of B to 100% at 17 min and an isocratic elution at 18 min.
The gradient was then reversed at 6 min followed by a stabilization after 3 min at a flow rate of
0.5 mL/min. The injected volume was 10 µL.
Then using an ESI-ion trap mass spectrometer (Esquire HCT ion trap mass spectrometer; Bruker,
Rheinstetten, Germany), the fraction of interest was characterized. The ESI was operated in the positive
mode. Mass spectrometer parameters were set as follows: capillary voltage -4500 V; endplate offset
−500 V; nebulizer pressure 50 psi; dry gas flow rate 10 L/min; dry gas temperature 300 ◦C; skimmer
20.6 V; capillary exit 300 V; oct 1 DC 10 V; oct 2 DC 2.79 V; Lens 1–5.2 V; lens 2–72 V; oct RF 300 Vpp;
trap drive 92.8. The scan range was optimized at 300–1250 m/z.
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2.6.4. NMR
The purified sample was diluted in D2O with TSP as internal standard and 2D (1H–13C) NMR
spectra were recorded at 300 K on a Bruker Avance NEO Ultrashield 700 Plus equipment operating at
700 MHz for 1H and 175 MHz for 13C and using a TCI cryo-probe (Rheinstetten, Germany).
For heteronuclear single quantum correlation (HSQC) experiments, the datasets were acquired
with 1024 and 512 data points for the f2 (1H) and f1 (13C) dimensions, with spectral widths of 11161
and 38736 Hz, respectively. Eight scans were performed and the relaxation delay was fixed at 1 s.
Regarding heteronuclear multiple bond correlation (HMBC) experiments, the datasets were
acquired with 4096 and 512 data points for the f2 (1H) and f1 (13C) dimensions, with spectral widths of
9091 and 38736 Hz, respectively. Thirty two scans were performed and the relaxation delay was fixed
at 1.5 s.
2.6.5. Colorimetric Test
In order to confirm the properties of the component, a colorimetric test based according to Prior
et al., 2010 [17] was performed. The DMAC (4-dimethylaminocinnamaldehyde) test has proven to
be effective when trying to quantify proanthocyanidins in plant extracts [18]. A 0.1 mg/mL sample
solution was prepared in pure ethanol. The DMAC solution was done following Prior’s protocol:
0.01 g of DMAC was placed in a 10 mL volumetric flask and a solution of 36% hydrochloric acid,
distilled water and pure ethanol (1:1:6) was added to the mark. The reaction was performed at room
temperature: 100 µL of sample solution was placed in a spectrophotometric cell added with 500 µL of
DMAC solution and read immediately at 640 nm.
3. Results and Discussion
3.1. Species Selection
Twenty-one species were selected after the ethnobotanical study in Mayotte (France) and their
crude extracts obtained with methanol and dichloromethane were used for biological in vitro testing
(data not shown). Among the 21 species tested, Litchi chinensis was the most promising, exhibiting
high anti-tyrosinase and antioxidant activities (95.1 ± 0.06%, 84.8 ± 1.87%, respectively).
3.2. Bioguided Fractionation
The bio-guided successive fractionation steps are illustrated in the different chromatograms
shown below (Figures 2–4). In each chromatogram, the peak that was selected after each fractionation
and biological activities evaluation (Tables 2–4) has been pointed out. In the first, fraction F10
was selected (Figure 2) because of its biological activities (Table 2); in the second one, F10.3 was
selected because of its biological activities (Table 3) (Figure 3). The identification work took place on
peak F10.3.3 (Figure 4), and its biological activities can be found in Table 4, obtained after the third
fractionation/purification step.
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Figure 4. Chromatogram from the third fractionation process (analytical HPLC with fraction collector).
Five fractions were isolated. The peak of interest is F10.3.3 (RT = 43′49”) (shown in red).
The Tables 2–4 present the relative anti-tyrosinase and antioxidant activities of each fraction
collected respectively after one, two or three HPLC purification step(s). In Table 2, the fraction 10
is highlighted for its high anti-tyrosinase and antioxidant activities and was further fractionated
into sub-fractions (Table 3) where fraction 10.3 was selected for the third fractionation step (Table 4).
The molecular characterization took place on fraction 10.3.3.
Table 2. Relative activity shown by the fractions retrieved after the first purification process.
Fraction
DPPH Tyrosinase
Inhibition % SD % Inhibition % SD %
1 97.7 0.53 37.4 3.69
2 59.6 5.16 12.7 8.75
3 56.8 7.05 11.0 1.74
4 3.43 1.76 20.8 15.7
5 91.2 4.40 28.6 7.30
6 50.8 3.75 0.03 0.06
7 96.4 0.74 78.6 0.74
8 95.6 0.40 76.9 5.42
9 98.8 0.55 55.2 1.32
10 97.1 0.72 87.4 0.85
11 97.5 0.66 65.2 1.16
12 22.1 5.35 6.35 1.07
13 97.5 0.33 35.8 4.45
14 96.8 0.64 77.2 0.19
15 90.0 9.19 75.6 2.32
16 89.0 9.91 28.1 1.71
17 16.9 4.39 0.00 0.00
Second Fractionation Activities
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Table 3. Relative activity shown by the fractions retrieved after the second purification process.
Fraction
DPPH Tyrosinase
Inhibition % SD % Inhibition % SD %
10.1 28.6 13.2 35.8 4.45
10.2 18.0 5.07 57.1 0.90
10.3 72.6 10.2 82.4 0.87
10.4 35.3 22.7 52.5 3.35
10.5 32.0 15.3 51.9 3.14
Third Fractionation
Table 4. Relative activity shown by the fractions retrieved after the third purification process.
Fraction
DPPH Tyrosinase
Inhibition % SD % Inhibition % SD %
10.3.1 28.6 13.2 0.0 0.0
10.3.2 18.0 5.07 0.0 0.0
10.3.3 72.6 10.19 8.44 1.59
10.3.4 35.3 22.7 1.18 1.21
10.3.5 32.0 15.28 0.0 0.0
3.3. Molecular Characterization
Combining the three successive fractionation steps allowed us to obtain fraction 10.3.3 that was
re-analyzed by analytical HPLC revealing a single peak with >99% UV-purity. Starting from 20 g of
litchi dry roots, we obtained around 9 mg of fraction 10.3.3 (protocol yield of 0.045 g/Kg DM).
3.3.1. IR
The most striking feature of the infrared spectrum (Figure 5) is the intense and relatively broad
band around 1600 cm−1. Such an intense band is not expected from double bond stretching vibration
but has been observed in molecules with 1,3-diketone moiety. The band is thought to result from
the resonance and the formation of a strong hydrogen bond when one of the ketones enolizes. Carbonyl
stretching bands are sometimes observed in 1,3-diketones infrared spectrum but the intensity of
the bands is highly variable according to the molecular structure. 1,3-dihydroxy aromatic structures
such as resorcinol and phloroglucinol also show an intense band around 1600 cm−1 and no intense
band in the carbonyl region of the spectrum. This could suggest that the isolated molecule is a phenolic
compound possessing −OH moieties in 1,3 positions. The occurrence of a small node at 3543 cm−1
suggests an intermolecular bonded −OH. The strong band at 1065 cm−1 can be explained by C-O
stretching from ether bond.
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3.3.2. Mass Spectrometry
Based on the mass spectrum (Figure 6), signal at 1153.1 m/z corresponded to [M + H]+, indicating
a monoisotopic mass of 1152.1 Da for the purified molecule. When compared to the literature,
the observed parent ion is in line with the observations of Lv Q. et al., 2015 and Xu X. 2010 [19,20]
and suggests a proanthocyanidin tetramer with two B-type bonds and one A-type bond (Figure 8).
The following information obtained from the mass spectrum was consistent with that conclusion.
Signal at 1001.1 corresponded to the loss of an hydroxyvinylbenzenediol unit [M H − 152]+, as
previously described by Enomoto H. et al., 2020 [21]. The most abundant ion of the ass spectrum
(865.2 m/z) was formed by quinone methide fission which caused the loss of the first epicatechin unit
linked with a single B-type 5–4′ bond. The 865.2 m/z ion thus corresponded to an epicatechin trimer
[M + H − 288]+. Sodium adduct of the latter is also reported at 887.2 m/z [M + Na − 288]+, as well as
the formation of a ion resulting from a water molecule loss to the tri er at 847.2 m/z [M + H – 288 −
H2O]+. The signal at 713.2 was produced following the loss of a h droxyvinylbenzened ol unit from
th epicathechin trimer [M + H – 288 − 152]+. Specific fragment ions at 575.1 and 865.2 al owed to
elucidate the position of the A-type double 5–4’/2-O-3’ (Figure 8) as those fragments are produced
when the A-ty e bond is placed between the second and the third ep catechin units [22,23].
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(154, 144, 131, 108, 106, 99 ppm). The quaternary C around 154 and 144 ppm are supposed to be linked
to O in opposition to the 99 ppm and 130 ppm ones. The molecule does not seem to possess ketone,
aldehyde or carboxylic acid moieties but includes an aliphatic part as suggested by several HSQC C-H
signals (yellow, blue and red circles in Figure 7) and a CH2 signal (grey circle in Figure 7). From HSQC
and HMBC data, this saturated structure is likely a heterocycle containing one oxygen atom. Several
signals support the connection of the heterocycle to two aromatic structures: 1H at 5.55 ppm coupled
to 13C at 115, 119 and 130 ppm; 1H at 2.8 and 2.7 ppm coupled to 13C at 154 and 100 ppm. A more
detailed allocation of HMBC signals is provided in Supplementary Materials (Figure S6).
Biomolecules 2020, 10, x FOR PEER REVIEW 11 of 14 
 
Figure 7. Two-dimensional heteronuclear single quantum correlation (HSQC) NMR spectrum of the 
isolated compound (right) and its hypothetical chemical structure (left). The structure proposal is 
based on both NMR and mass spectrometry data. 
Using the NMR results coupled with IR results and the typical mass fragments, the isolated 
molecule is a proanthocyanidin composed of four catechins as seen in Figure 8. 
3.3.4. UV 
As mentioned in the work of Hümmer & Schreier, 2008 [25], the presence of proanthocyanidin 
is characterized by a peak around 200–220 nm and a peak at 278 nm, this information is aligned with 
the UV spectra obtained from the isolated molecule (data not shown). 
3.3.5. Colorimetric Test 
The Optical Density of the blanks and the sample were as follows (Table 5): 
Table 5. Optical density at 640 nm of the fraction 10.3.3 in contact with 4-
dimethylamincinnamaldehyde (DMAC). 
Observation MeOH DMAC 1mg/mL HCl + EtOH Sample Sample + DMAC 
Optical density 0.00 ± 0.000 0.13 ± 0.00 0.00 ± 0.00 0.24 ± 0.00 0.46 ± 0.08 
Based on the works of Q. Lv et al. (2015) M. J. Payne et al. (201) Y. Wang et al. (2016) [19,26,27], 
the compound reacts with DMAC, in a way that allows us to confirm the procyanidin nature of the 
compound as well as the presence of A linkage  
Finally, when comparing all the available information, the isolated compound is a A-type 
procyanidin tetramer with the following structure: EC -->B --> EC --> A -->EC --> B --> EC where EC stands 
for epicatechin, B stands for a single 5-4′ bond and A stands for a double 5-4′/2-O-3′ bond (Figure 8). 
Figure 7. Two-dimensional heteronuclear single quantum correlation (HSQC) NMR spectrum of
the isolated compound (right) and its hypothetical chemical structure (left). The structure proposal is
based on both NMR and mass spectrometry data.
NMR data thus confirm that the molecule is a catechin derivative. This complies with the techniques
used when isolating and purifying the compound [19,24] as well as when comparing to the available
literature on the phytochemistry of Litchi [13].
If the catechin structure seems relevant, there are still too many signals corresponding to aromatic
C-H, non-aromatic hydroxylated C-H and non-aromatic C-H. As suggested by mass spectrometry,
several elements of NMR spectra support that the molecule is an oligomer, probably a tetramer from
the repetitive patterns observed in HSQC and HMBC experiments:
- In HSQC, four signals are observed for non-aromatic hydroxylated C-H (red circle, Figure 7).
- In HMBC, four aromatic 1H (two around 6.9 ppm and two around 6.8 ppm) are also coupled to
13C with a common pattern (131; 144 ppm).
- In HSQC, the presence of signals at 4.2; 27 and 4.3; 36 ppm (Figure 7, yellow circle) can be
explained if several catechin units are linked together since unpolymerized catechin should only
display CH2 signals in this area of the spectrum.
- In HMBC, the B-type bond between units is confirmed by the coupling of 1H at 4.3 ppm with 13C
at 154, 153, 151, 108, 106, 77 and 71 ppm. Signals at 4.3; 154,153 and 151 ppm correspond to H5
coupled to C1’, C3 and C3′. The coupling of H5 with C4 and C4′ are also expected and probably
correspond to signals at 4.3; 108 and 106 ppm, respectively (HMBC spectrum in Figure S5).
The presence of an A-type bond in the molecule is also confirmed by NMR data. Two distinct
chemical shifts are attributed to carbon C2: 77–78 ppm and 99 ppm. The increased chemical shift
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(99 ppm) of carbon C2 (Figure 8) is consistent with its involvement in an A-type bond which implies
an additional bond to an oxygen atom.
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that could be used for the development of effective skin treatment. The fact that L. chinensis roots are 
used in this study may raise questions in terms of the plant's conservation. However, technologies 
exist to enhance the value of root plant compounds [31]. In the end, our study has allowed the 
purification and the characterization of a proanthocyanidin A-type in L. chinensis roots for the first 
Figure 8. Purified compound from the roots of L. chinensis.
Using the NMR results coupled with IR results and the typical mass fragments, the isolated
molecule is a proanthocyanidin composed of four catechins as seen in Figure 8.
3.3.4. UV
As mentioned in the work of Hümmer & Schreier, 2008 [25], the presence of proanthocyanidin is
characterized by a peak around 200–220 nm and a peak at 278 nm, this information is aligned with
the UV spectra obtained from the isolated molecule (data not shown).
3.3.5. Colorimetric Test
The Optical Density of the blanks and the sample were as follows (Table 5):




1mg/mL HCl + EtOH Sample
Sample +
DMAC
Optical density 0.00 ± 0.000 0.13 ± 0.00 0.00 ± 0.00 0.24 ± 0.00 0.46 ± 0.08
Based on the works of Q. Lv et al. (2015) M. J. Payne et al. (201) Y. Wang et al. (2016) [19,26,27],
the compound reacts with DMAC, in a way that allows us to confirm the procyanidin nature of
the compound as well as the presence of A linkage.
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Finally, when comparing all the available information, the isolated compound is a A-type
procyanidin tetramer with the following structure: EC –>B –> EC –> A –>EC –> B –> EC where EC
stands for epicatechin, B stands for a single 5-4′ bond and A stands for a double 5-4′/2-O-3′ bond
(Figure 8).
When comparing the determined structure to the available literature, a compound showing
similar structure and mass is (2R,3R,4S,8R,14R,15R)-2,8-Bis(3,4-dihydroxyphenyl)-10-[(2R,3R,4R)-2-
(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-4-yl]-4-[(2R,3S)-2-(3,4-
dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-8-yl]-3,4-dihydro-8,14-methano-
2H,14H-1-benzopyrano[7,8-d][1,3]benzodioxocin-3,5,11,13,15-pentol or cinnamtannin D2 (CAS registry
number 97233-47-1). This molecule was previously described in peanut skin (Arachis hypogaea L.,
Fabaceae; [28].
4. Conclusions
This work is part of a bigger study aiming to identify compounds of interest in the wide flora
available in the Comoros archipelago. In this specific case, an anti-tyrosinase activity is interesting
when willing to treat issues such as melasma [29]. This kind of skin condition implies the local
application of compound is destined to regulate melanogenesis. Treatments used nowadays can be
very dangerous as they often contain hydroquinone and steroids. Those compounds have shown
adverse effects such as dermatitis, black and blue skin pigmentation, blindness, skin thinning, bruises
and stretch marks. This means that there is room for effective treatment without any adverse effect
especially when taken for a long period of time, as it is often requested for those types of diseases [30].
In addition, the antioxidant potency of the samples were tested, as it is also beneficial when working
with topical treatments. Through a bio-guided purification followed by molecular characterization
of extracts from the roots of Litchi chinensis Sonn., the structure of cinnamtannin D2 responsible for
the biological activity was obtained. It is the first time that this class of compounds was highlighted in
L. chinensis’ roots. Lychee roots appear to be a promising source of raw material that could be used for
the development of effective skin treatment. The fact that L. chinensis roots are used in this study may
raise questions in terms of the plant’s conservation. However, technologies exist to enhance the value of
root plant compounds [31]. In the end, our study has allowed the purification and the characterization
of a proanthocyanidin A-type in L. chinensis roots for the first time. This study also revealed a consensus
among the chemical structure, biological activities and the traditional uses of Litchi roots in Mayotte to
treat skin pigmentation issues and soften the skin.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/9/1347/s1,
Figure S1: 1D 1H NMR spectrum of the isolated compound, Figure S2: 2D HMBC NMR spectrum of the isolated
compound, Figure S3: 2D HMBC NMR spectrum of the isolated compound, Figure S4: 2D HMBC NMR spectrum
of the isolated compound, Figure S5: 2D HMBC NMR spectrum of the isolated compound, Figure S6: Allocation
of 2D HMBC NMR signals of the isolated compound.
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